Innate Immunity and Steatohepatitis: A Critical Role of Another Toll (TLR-9)

Gastroenterology

Volumn 139, Issue 1, 2010, Pages 27-30

  Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 9;

EDITORIAL; FATTY LIVER; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION;

EID: 77953896797     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.05.018     Document Type: Editorial

References (31)

1. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119 (2009) 1745-1754
2. Ahlenstiel G., Titerence R.H., Koh C., et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138 (2010) 325-335
3. Maher J.J., Leon P., and Ryan J.C. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology 48 (2008) 670-678
4. Valenti L., Fracanzani A.L., and Fargion S. The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?. Semin Immunopathol 31 (2009) 359-369
5. Pritchard M.T., McMullen M.R., Medof M.E., et al. Role of complement in ethanol-induced liver injury. Adv Exp Med Biol 632 (2008) 175-186
6. Torres D.M., and Harrison S.A. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134 (2008) 1682-1698
7. Gao B., Jeong W.I., and Tian Z. Liver: An organ with predominant innate immunity. Hepatology 47 (2008) 729-736
8. Seki E., and Brenner D.A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48 (2008) 322-335
9. Mencin A., Kluwe J., and Schwabe R.F. Toll-like receptors as targets in chronic liver diseases. Gut 58 (2009) 704-720
10. Szabo G., Dolganiuc A., and Mandrekar P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 44 (2006) 287-298
11. Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50 (2009) 638-644
12. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48 (2001) 206-211
13. Arteel G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124 (2003) 778-790
14. Hritz I., Mandrekar P., Velayudham A., et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48 (2008) 1224-1231
15. Zhao X.J., Dong Q., Bindas J., et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 181 (2008) 3049-3056
16. Spruss A.K.G., Wagnerberger S., Haub S., et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50 (2009) 1094-1104
17. Rivera C.A., Adegboyega P., van Rooijen N., et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 47 (2007) 571-579
18. Szabo G., Velayudham A., Romics Jr. L., et al. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 29 (2005) 140S-145S
19. Miura K., Kodama Y., Inokuchi S., et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice. Gastroenterology 139 (2010) 323-334
20. Stienstra R., Saudale F., Duval C., et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 51 (2010) 511-522
21. Jiang W., Sun R., Zhou R., et al. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J Immunol 182 (2009) 3768-3774
22. Bamboat Z.M., Ocuin L.M., Balachandran V.P., et al. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120 (2010) 559-569
23. Bamboat Z.M., Balachandran V.P., Ocuin L.M., et al. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51 (2010) 621-632
24. Kikuchi K., Lian Z.X., Yang G.X., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128 (2005) 304-312
25. Martin-Armas M., Simon-Santamaria J., Pettersen I., et al. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J Hepatol 44 (2006) 939-946
26. Imaeda A.B., Watanabe A., Sohail M.A., et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 119 (2009) 305-314
27. Gabele E., Muhlbauer M., Dorn C., et al. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun 376 (2008) 271-276
28. Watanabe A., Hashmi A., Gomes D.A., et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46 (2007) 1509-1518
29. Gustot T., Lemmers A., Moreno C., et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43 (2006) 989-1000
30. Dalpke A.H., Lehner M.D., Hartung T., et al. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 116 (2005) 203-212
31. De Nardo D., De Nardo C.M., Nguyen T., et al. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J Immunol 183 (2009) 8110-8118